Targeting aberrant end-joining repair for improving treatment of mixed phenotype acute leukemia

Active Project Grant Awarded Last action

Award ID
HT9425261E419
Recipient
Awarding agency
Obligated
$1,399,965

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 6% complete
Place of performance
Irwindale, CA 91010, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded $1.399 million to Beckman Research Institute of the City of Hope on August 31, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research targeting aberrant end-joining repair for improving treatment of mixed phenotype acute leukemia. The award runs through July 31, 2029, with performance at Beckman's Irwindale, California facility. This project grant supports basic and applied biomedical research to transform health care for Service Members and the American public through innovative research addressing medical solutions relevant to military operations.

Quick answers

Who received award HT9425261E419?

HT9425261E419 was awarded to Beckman Research Institute Of The City Of Hope by Defense Health Agency (Department of Defense) on August 31, 2026.

How much is award HT9425261E419 worth?

$1,399,965 has been obligated on HT9425261E419.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login